A clinical trial conducted in China has provided encouraging evidence regarding the efficacy of gene therapy for a rare form of deafness.
The results indicate that 90% of participants experienced significant improvements in their hearing following the treatment.
These findings may contribute to the growing body of research supporting gene therapy as a viable option for addressing certain types of hearing loss.